title: Corrigendum to "Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study" [Park. Relat. Disord. 28 (2016) 49-55].
authors.affiliation: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
authors.forename: Zhen-Xin
authors.initials: ZX
authors.lastname: Zhang
authors.affiliation: West China Hospital, Sichuan University, Chengdu, Sichuan, China.
authors.forename: Hui-Fang
authors.initials: HF
authors.lastname: Shang
authors.affiliation: Sir Run Run Shaw Hospital affiliated to School of Medicine, Zhejiang University, Zhejiang, China.
authors.forename: Xingyue
authors.initials: X
authors.lastname: Hu
authors.affiliation: Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
authors.forename: Shengdi
authors.initials: S
authors.lastname: Chen
authors.affiliation: Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
authors.forename: Zhongxin
authors.initials: Z
authors.lastname: Zhao
authors.affiliation: UCB Pharma, Shanghai, China.
authors.forename: Xinlu
authors.initials: X
authors.lastname: Du
authors.affiliation: UCB Pharma, Monheim am Rhein, Germany.
authors.forename: Erwin
authors.initials: E
authors.lastname: Surmann
authors.affiliation: UCB Pharma, Monheim am Rhein, Germany. Electronic address: lars.bauer@ucb.com.
authors.forename: Lars
authors.initials: L
authors.lastname: Bauer
authors.affiliation: UCB Pharma, Raleigh, NC, USA.
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Asgharnejad